DETECTION OF URINARY MESOTHELIN-/MEGAKARYOCYTE POTENTIATING FACTOR-RELATED PEPTIDES FOR ASSESSMENT OF MESOTHELIOMA

摘要

The invention relates to methods and kits for assessing occurrence in patient urine of peptides having amino acid sequences related to those of mesothelin, megakaryocyte potentiating factor, and other peptides that have been associated with occurrence in the serum of mesothelioma patients. The methods and kits can be used to diagnose mesothelioma in a patient, to predict development of mesothelioma in an otherwise asymptomatic patient, or to assess the efficacy of a mesothelioma therapeutic method.